Bevacizumab

Jump to navigation Jump to search

Bevacizumab is an anti-angiogenic drug that is used in the treatment of Metastatic Renal cell carcinoma, Metastatic breast cancer, Non-small cell lung cancer, and is also approved in the treatment Glioblastoma multiforme.[1]

References

  1. Bevacizumab Gets Fast-Track Approval for Glioblastoma. www.medpagetoday.com (6 May 2009).